Drug Shortage Report for PMS-LOSARTAN

Last updated on 2024-07-10 History
Report ID 214340
Drug Identification Number 02309750
Brand name PMS-LOSARTAN
Common or Proper name LOSARTAN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-22
Estimated end date 2024-06-03
Actual end date 2024-07-09
Shortage status Resolved
Updated date 2024-07-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-12-27 English Compare
v2 2023-12-27 French Compare
v3 2024-03-15 English Compare
v4 2024-03-15 French Compare
v5 2024-04-29 English Compare
v6 2024-04-29 French Compare
v7 2024-05-10 English Compare
v8 2024-05-10 French Compare
v9 2024-05-22 English Compare
v10 2024-05-22 French Compare
v11 2024-07-10 English Compare
v12 2024-07-10 French Compare

Showing 1 to 12 of 12